Eagle Pharmaceuticals, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7 8 9 10
Rok finansowy 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Przychód (mln) 3 14 19 66 189 237 213 196 188 172 317
Przychód Δ r/r 0.0% 438.8% 39.6% 246.8% 186.1% 24.9% -9.9% -8.2% -4.1% -8.7% 84.6%
Marża brutto -24.7% 46.0% 38.7% 76.4% 70.8% 75.8% 71.0% 68.9% 75.8% 75.4% 70.0%
EBIT (mln) -20 -8 -19 3 53 74 37 22 25 -3 53
EBIT Δ r/r 0.0% -57.4% 121.8% -113.6% 1984.0% 38.7% -50.5% -40.4% 15.8% -111.5% -1935.0%
EBIT (%) -781.1% -61.8% -98.2% 3.9% 28.2% 31.3% 17.2% 11.1% 13.4% -1.7% 16.9%
Koszty finansowe (mln) 0 1 0 0 0 1 3 3 3 2 4
EBITDA (mln) -20 -8 -19 3 52 79 50 29 30 1 65
EBITDA(%) -770.5% -61.5% -97.9% 3.9% 27.3% 33.5% 23.6% 15.0% 16.0% 0.5% 20.7%
Podatek (mln) -1 -1 -1 0 -28 21 2 8 11 4 26
Zysk Netto (mln) -19 -6 -18 3 81 52 32 14 12 -9 36
Zysk netto Δ r/r 0.0% -68.8% 197.2% -114.3% 3068.1% -36.2% -38.6% -55.1% -16.2% -172.0% -513.1%
Zysk netto (%) -763.4% -44.2% -94.1% 3.9% 43.0% 21.9% 15.0% 7.3% 6.4% -5.0% 11.3%
EPS -1.83 -0.57 -1.81 0.17 5.24 3.44 2.16 1.04 0.89 -0.66 2.76
EPS (rozwodnione) -1.83 -0.57 -1.81 0.16 4.96 3.27 2.09 1.01 0.87 -0.66 2.73
Ilośc akcji (mln) 11 11 10 15 16 15 15 14 13 13 13
Ważona ilośc akcji (mln) 11 11 10 16 16 16 15 14 14 13 13
Waluta USD USD USD USD USD USD USD USD USD USD USD